An Effective Drug Is Not Enough: How Do We Improve Access to Molecular Testing to Enable Personalized Treatment in Oncology?
Author(s)
Moderator: Brittany Carson, PhD, MHEcon, ApotheCom, New York, NY, USA
Speakers: Alison Urvalek, PhD, Loxo@Lilly, Astoria, NY, USA; Jessica Roydhouse, PhD, Menzies Institute for Medical Research, Hobart, TAS, Australia
Precision oncology has allowed for more personalized treatment, often requiring molecular testing to identify those expected to show improved clinical benefit compared with other treatment options. However, access to testing can be limited by a wide range of barriers. Despite efforts to address these barriers, challenges remain, and the consideration of multiple stakeholder perspectives will be necessary to identify effective solutions. In this forum session led by ISPOR’s Oncology SIG, the panelists will discuss barriers to molecular testing access in cancer care from the patient, research, and industry perspectives. The goal of this forum is to better characterize this multifaceted issue, including current evidence gaps, and identify practical and impactful solutions that will be feasible from the HEOR perspective, optimizing patient outcomes while minimizing additional costs. Dr. Urvalek will give a 10-minute presentation on industry-led initiatives and studies aimed at removing barriers to molecular testing and measuring impact. These collaborations involve community-based hospitals, diagnostic companies, and payors. Dr. Roydhouse will give a 10-minute presentation on research examining patient perceptions regarding the use of genetic information in cancer diagnosis and treatment. She will also present research and data collection considerations for understanding the impact and use of molecular testing outside of the clinical trial setting. Presentations will be followed by a moderated discussion and Q&A session with the audience. Outputs of the forum will inform future SIG activities, including a potential follow-up publication.
Conference/Value in Health Info
2023-11, ISPOR Europe 2023, Copenhagen, Denmark
Code
138
Topic
Health Policy & Regulatory